Last reviewed · How we verify
NCT06621589: ECHO-OFEM
Effect of Nutritional Counseling on Health Outcomes in Female Workers Wih Obesity at Adam Malik Hospital
NA trial testing Nutritional Counseling in Obesity in 97 participants. Completed in 25 November 2024.
25 October 2024
Quick facts
| Lead sponsor | RS H Adam Malik |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 97 |
| Start date | 26 August 2024 |
| Primary completion | 25 October 2024 |
| Estimated completion | 25 November 2024 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Nutritional Counseling
Conditions studied
- Obesity — all drugs for Obesity →
Sponsor
RS H Adam Malik
Who can join
Adults 24 to 63, female only, with Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this quasi-experimental study is to determine whether nutritional counseling can improve health outcomes in female workers with obesity at Adam Malik Hospital in Medan. Specifically, the study aims to assess the impact of nutritional counseling on participants; anthropometric measurements, body composition, total cholesterol, blood glucose, uric acid levels, as well as on attitudes, and behavioral changes. The main questions it aims to answer are: * What are the effects of nutritional counseling on anthropometric measurements, body composition, total cholesterol, blood glucose, uric acid levels? * How does nutritional counseling affect attitudes toward healthy eating and changes in health behaviors? Researchers will compare the health metrics of participants before and after receiving nutritional counseling to evaluate its effectiveness. Participants will: * Attend personalized nutritional counseling sessions over a period of 2 months. * Complete assessments that include anthropometric measurements (weight, height, BMI), body composition analysis, and blood tests for total cholesterol, blood glucose, uric acid levels * Fill out questionnaires to provide information on their attitudes, and health behaviors before and after the intervention. This study aims to provide insights into the benefits of nutritional counseling in improving various health outcomes among obese female employees.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06621589
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Nutritional Counseling
Trials testing the same drug.
- NCT07479940 — Obesity and Aging: Impacts of Nutritional Counseling and Physical Exercise on Telomeres and Senescence Parameters · NA · active not recruiting
- NCT06784310 — Food Insecurity, Social Determinants of Health · NA · completed
- NCT06610097 — TNBC Gut Microbiota During Neoadjuvant Treatment · NA · recruiting
- NCT06751290 — The Use of Cyproheptadine in Pediatric Feeding Disorders · Phase 4 · active not recruiting
- NCT06673342 — Effectiveness of a Nutritional Counseling Tool in Reducing the Amount and Frequency of Sugar Intake · NA · completed
Other recruiting trials for Obesity
Currently open trials in the same condition.
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
- NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
- NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
- NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
- NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting
Other RS H Adam Malik trials
Trials by the same sponsor.
- NCT06109168 — Correlation of SpO2/FIO2 Ratio With PaO2/FIO2 Ratio in ARDS Patients in the ICU of H. Adam Malik Hospital · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06621589 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RS H Adam Malik
- Last refreshed: 4 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06621589.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing